Does the intact nephron hypothesis provide a reasonable model for metformin dosing in chronic kidney disease?

Abstract

This research explored the intact nephron hypothesis (INH) as a model for metformin dosing in patients with chronic kidney disease. The INH assumes that glomerular filtration rate (GFR) will account for all kidney drug handling even for drugs eliminated by tubular secretion like metformin. We conducted two studies; 1) a regression analysis to explore the relationship between metformin clearance and eGFR metrics, and 2) a joint population pharmacokinetic analysis to test the relationship between metformin renal clearance and gentamicin clearance. The relationship between metformin clearance and eGFR metrics and gentamicin clearance was found to be linear suggesting that a proportional dose reduction based on GFR in patients with CKD is reasonable.